期刊文献+

乙肝肝硬化相关早期肝癌切除术预后 被引量:37

Prognosis after resection of early hepatocellular carcinoma in HBV-related cirrhotic patients
原文传递
导出
摘要 目的研究乙肝肝硬化相关早期肝癌肝切除术复发危险因素及预后。方法通过临床监测、流行病学和终末结果数据库确诊早期肝癌,包括肿瘤直径≤5cm,没有肝内转移灶、远处转移或者主要血管侵犯。所有患者均施行肝切除术(不包括射频及肝移植术)。2005年4月至2010年11月东方肝胆外科医院共确诊肝癌患者20700例。本文回顾性分析其中537例早期肝癌患者的临床特点和预后因素。生存分析使用Kaplan-Meier函数及Cox模型。结果537例乙肝肝硬化早期肝癌患者的中位肿瘤直径为2.9cm,其中33%的患者肿瘤直径≤2em。绝大多数早期肝癌患者肿瘤单发(63%)且没有血管侵犯证据(64%)。术后总体中位生存时间及5年生存率分别为45个月及33%。综合分析年龄、性别及病理分期等因素显示,肿瘤直径〉2cm[风险比(HR):1.56]、多病灶(HR:1.34)、血管侵犯(HR:2.03)为影响预后的独立危险因素(P〈0.05)。根据这些研究结果,建立一个早期肝癌预后评分系统,分成4个组(中位生存时间及5年生存率),0分(97个月,96%),1分(85个月,76%),2分(76个月,54%),3分(56个月,39%),各组间差异有统计学意义(P〈0.01)。结论病理分期对于早期肝癌手术预后的判断具有重要意义,解剖性肝切除是乙肝肝硬化相关早期肝细胞癌患者最佳手术选择。 Objective To identifyclinicopathologic factors which predict survival following hepatectomy in HBV-related cirrhotic patients with early hepatocellular carcinoma (HCC). Methods A database was used to identify patients with histologically confirmed early HCC ( ≤5 cm, no nodal involvement, metastases, or major vascular invasion) who underwent surgical resection (excluding ablation or transplantation). Among 20 700 patients with HCC who were diagnosed at the Eastern Hepatobiliary Surgery Hospital from April 2005 to November 2010, 537 (2.6%) patients with early HCC were studied retrospectively. Prognostic factors were evaluated using the Kaplan-Meier curves, Cox proportional hazards models and the receiver operating characteristic (ROC) curves. Results The study included 537 patients. The median tumor size was 2.9 em, and 33% of patients had tumors ≤2 cm. Most HCC lesions were solitary (63%) and had no evidence of vascular invasion (64%). Following surgery, the overall median and 5-year survival were 45 months and 33% respectively. After adjusting for demographic factors and histological grade, tumor size 〉 2 cm ( hazard ratio [ HR ] : 1.56), multifocal tumors ( HR : 1.34), and vascular invasion ( HR : 2.03 ) remained independent predictors of poor survival ( all P 〈 0.05 ). Based on these findings, a prognostic sco- ring system was developed that allotted 1 point each for these factors. Patients with early HCC could be strat- ified into 4 distinct prognostic groups ( median and 5-year survival, respectively) : 0 points ( 97 months, 96%), 1 point (85 months, 76%), 2 points (76 months, 54%), 3 points (56 months, 39%) (P 〈 0.01 ). Conclusions The present study emphasized the importance of pathologic staging even in patients with small HCC. Anatomical resection of HCC should be the preferred surgical procedure in cirrhotic patients.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第4期258-264,共7页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:国家重大科技基金(2008ZX10002-025)
关键词 肝细胞癌 肝硬化 预后 肝切除 危险因素 Hepatocellular carcinoma Cirrhosis Prognosis Hepatic resection Risk factors
  • 相关文献

参考文献39

  • 1陈杰,李相成.早期肝癌的手术治疗:肝切除与肝移植比较[J].中华肝胆外科杂志,2010,16(10):794-797. 被引量:7
  • 2刘立国,吴健雄.乙肝病毒因素对肝癌肝切除及肝移植术后复发的影响[J].中华肝胆外科杂志,2012,18(5):398-400. 被引量:12
  • 3McGlynn KA,London WT.The global epidemiology of hepatocellular carcinoma:present and future[J].Clin Liver Dis,2011,15(2):223-243.
  • 4Kobayashi M,Ikeda K,Hosaka T,et al.Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections[J].J Med Virol,2006,78(4):459-465.
  • 5Davila JA,El-Serag HB.Racial differences in survival of hepatocellular carcinoma in the United States:a population-based study[J].Clin Gastroenterol Hepatol,2006,4(1):104-110.
  • 6Duffy JP,Hiatt JR,Busuttil RW.Surgical resection of hepatocellular carcinoma[J].Cancer J,2008,14(2):100-110.
  • 7El-Serag HB,Marrero JA,Rudolph L,et al.Diagnosis and treatment of hepatocellular carcinoma[J].Gastroenterology,2008,134(6):1752-1763.
  • 8Bruix J,Sherman M.Management of hepatocellular carcinoma[J].Hepatology,2005,42(5):1208-1236.
  • 9Zhang BH,Yang BH,Tang ZY.Randomized controlled trial of screening for hepatocellular carcinoma[J].J Cancer Res Clin Oncol,2004,130(7):417-422.
  • 10Takayama T,Makuuchi M,Hirohashi S,et al.Early hepatocellular carcinoma as an entity with a high rate of surgical cure[J].Hepatology,1998,28 (5):1241-1246.

二级参考文献33

  • 1Miao, Ruo-Yu,Zhao, Hai-Tao,Yang, Hua-Yu,Mao, Yi-Lei,Lu, Xin,Zhao, Yi,Liu, Chang-Ning,Zhong, Shou-Xian,Sang, Xin-Ting,Huang, Jie-Fu.Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis[J].World Journal of Gastroenterology,2010,16(23):2931-2942. 被引量:27
  • 2董梅.乙肝病毒基因型的研究进展及临床意义[J].武警医学院学报,2005,14(4):319-322. 被引量:5
  • 3Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000.Int J Cancer,2001,94:153-156.
  • 4Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med,1996,334:693-699.
  • 5Poon RT,Fan ST,Lo CM,et al.Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function:implications for a strategy of salvage transplantation.Ann Surg,2002,235:373-382.
  • 6Cha CH,Ruo L,Fong Y,et al.Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation.Ann Surg,2003,238:315-321.
  • 7Margarit C,Escartin A,Castells L,et al.Resection for Hepatocellular Carcinoma is a Good Option in Child-Turcotte-Pugh Class A Patients With Cirrhosis Who Are Eligible for Liver Transplantation.Liver Transpl,2005,11:1242-1251.
  • 8Shah SA,Cleary SP,Tan JC,et al.An Analysis of Resection vs Transplantation for Early Hepatocellular Carcinoma:Defining the Optimal Therapy at a Single Institution.Ann Surg Oncol,2007,14:2608-2614.
  • 9Baccarani U,Isola M,Adani GL,et al.Superiority of Transplantation Versus Resection for the Treatment of Small Hepatocellular Carcinoma.Transpl Int,2008,21:247-254.
  • 10Bigourdan JM,Jaeck D,Meyer N,et al.Small Hepatocellular Carcinoma in Child A Cirrhotic Patients:Hepatic Resection Versus Transplantation.Liver Transpl,2003,9:513-520.

共引文献17

同被引文献431

引证文献37

二级引证文献224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部